Home/Filings/4/0000950170-24-114683
4//SEC Filing

Fleming Harold Edward 4

Accession 0000950170-24-114683

CIK 0002022626other

Filed

Oct 14, 8:00 PM ET

Accepted

Oct 15, 4:15 PM ET

Size

5.7 KB

Accession

0000950170-24-114683

Insider Transaction Report

Form 4
Period: 2024-10-10
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-10-10+17,09617,096 total
    Exercise: $17.00Exp: 2034-10-09Common Stock (17,096 underlying)
Footnotes (2)
  • [F1]The shares underlying this option shall vest upon the earlier of (i) October 10, 2025 and (ii) the date of the next Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continued service on such vesting date.
  • [F2]Mr. Fleming has agreed to receive and hold for the benefit of Enavate Sciences, LP, any securities granted to him for his service as a director on the Issuer's board of directors. As such, Mr. Fleming disclaims beneficial ownership of, and all right, title and interest in, the option and the shares issuable upon exercise thereof.

Documents

1 file

Issuer

Upstream Bio, Inc.

CIK 0002022626

Entity typeother

Related Parties

1
  • filerCIK 0001857250

Filing Metadata

Form type
4
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 4:15 PM ET
Size
5.7 KB